Michael Kresken

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Escherichia Coli

Multidrug Resistant

Genetic Diversity

Top Venues

Antibiotics (Basel, Switzerland)

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Esther Wohlfarth, Michael Kresken, Fabian Deuchert
Antimicrobial Susceptibility of Bacterial Pathogens from Patients with Ocular Surface Infections in Germany, 2020-2021: A Comparison with the Data from Three Previous National Studies. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Esther Wohlfarth, Michael Kresken, Fabian Deuchert
Antimicrobial Susceptibility of Bacterial Pathogens from Patients with Ocular Surface Infections in Germany, 2020-2021: A Comparison with the Data from Three Previous National Studies. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Esther Wohlfarth, Michael Kresken, Fabian Deuchert, Sören G Gatermann, Yvonne Pfeifer, Niels Pfennigwerth, Harald Seifert, Paul G Higgins, Guido Werner, null Study Group 'Antimicrobial Resistance' Of The Paul Ehrlich Society For Infection Therapy
In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17. Antibiotics (Basel, Switzerland) 12 (5) (2023)
Harald Seifert, Carina Müller, Danuta Stefanik, Paul G Higgins, Esther Wohlfarth, Michael Kresken
In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates. Antibiotics (Basel, Switzerland) 12 (7) (2023)
Michael Kresken, Yvonne Pfeifer, Florian Wagenlehner, Guido Werner, Esther Wohlfarth, On Behalf Of Study Group 'Antimicrobial Resistance' Of The Paul Ehrlich Society For Infection Therapy
Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Michael Kresken, Esther Wohlfarth, Chase Weikel, Deborah Butler, Yvonne Pfeifer, Guido Werner, null null
In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany. The Journal of antimicrobial chemotherapy (2022)